--- pretty_name: CDC NREVSS — weekly RSV test specimens and positives license: other size_categories: - 10K ## Coverage - **Time:** 2010-07-10 → 2020-06-27 - **Cadence:** `weekly` (observed median spacing: 7 days) - **Geography levels:** `subnational-region` — 10 unique location IDs - **Countries:** US - **Pathogens:** `rsv` - **Surveillance category:** `respiratory` - **Rows:** 10,313 ## Columns | Column | Unit | value_type | Aggregation | Description | |--------|------|------------|-------------|-------------| | `rsvpos` | specimens/week | `incident` | `sum` | Specimens testing positive for RSV (this test type, this region, this week) | | `rsvtest` | specimens/week | `incident` | `sum` | Total specimens tested for RSV | ### Additional data columns - **`testtype`** — `Antigen` or `PCR`. Always 2 rows per (date, region) — one per test type. Treat as a row-level dimension; downstream % positive is computed per testtype. - **`outlier`** — 1 = source itself flagged this point as an outlier (excluded from CDC's published trend). - **`location_name`** — `HHS N` for traceability. `location_id` (`US-HHS-N`) is canonical. ## Interpretation caveats Things that may differ from how other sources define a similar measure. If you're combining this dataset with another, read these first. - **`rsvtest`** — PCR vs antigen counts are NOT comparable. PCR ramped up post-2018; antigen has been the long-term backbone but is less sensitive. Don't sum across testtype — they're parallel signals. ## Access - **Availability:** `open` - **Access type:** `socrata` - **License:** other - **Tier:** 2 --- *Schema version `0.1` · Last ingested 2026-04-26T12:48:35Z · `source_id: cdc-nrevss-rsv` · Manifest section §1.6*